-
Mashup Score: 6Trends in Transcatheter Aortic Valve Replacement Outcomes - 2 month(s) ago
This cohort study examines changes in risk-adjusted transcatheter aortic valve replacement (TAVR) outcomes from 2019 to 2022 using data from the Society of Thoracic Surgeons (STS)/American College of Cardiology (ACC) Transcatheter Valve Therapies (TVT) Registry.
Source: jamanetwork.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 1
A new risk score shows potential to help cardiologists predict the risk of some TAVR complications before they happen, guiding important treatment decisions.
Source: cardiovascularbusiness.comCategories: General Medicine News, Cardiology News and JournTweet-
Predicting vascular complications during #TAVR just got a little easier @ACCmediacenter @ACCinTouch @ThomPilgrim @unibern @masaaki0825 @JACCJournals https://t.co/pXnMRJktpI
-
-
Mashup Score: 2Long-term survival after valve-in-valve TAVR similar with self-expanding, balloon-expandable valves - 3 month(s) ago
Severe prosthesis-patient mismatch was more common with balloon-expandable valves, but that difference did not appear to impact outcomes.
Source: cardiovascularbusiness.comCategories: General Medicine News, CardiologistsTweet-
Long-term survival after valve-in-valve #TAVR similar with self-expanding, balloon-expandable valves @IbrahimSultanMD @M_Pompeu_Sa_MD @UPMC_CTSurgery https://t.co/T7vXDfNwKf
-
-
Mashup Score: 6Transcatheter Aortic Valve Implantation: Two Decades of a Revolutionary and Ongoing Odyssey | Circulation - 4 month(s) ago
Few medical technologies have faced as many challenges and achieved as much success as transcatheter aortic valve implantation (TAVI), which is regarded as one of the most important medical breakthroughs in cardiology in recent decades. Developed in the face of skepticism, over the past 20 years TAVI has become the dominant therapy for calcific aortic stenosis (AS), the most common acquired heart valve disease, with a prevalenc e of 5% of the population > 70 years of age, and increasing with age. If left
Source: www.ahajournals.orgCategories: General Medicine News, CardiologistsTweet-
#TAVR : Two Decades of a Revolutionary and Ongoing Odyssey | Circulation a tribute to Alain Cribier https://t.co/7lP7nIbMG5
-
-
Mashup Score: 1
The J Valve from JC Medical was linked to positive outcomes and “excellent” hemodynamic data after 30 days in an early feasibility study published in JACC: Cardiovascular Interventions. Researchers noted that the valve showed potential in patients with large aortic annuli, which represents an “unmet critical need” at this stage.
Source: cardiovascularbusiness.comCategories: General Medicine News, CardiologistsTweet-
New #TAVR valve for native aortic regurgitation linked to positive 30-day outcomes @hahn_rt @JoaoLCavalcante @azeemlatib @MReardon19 @ChristHospital @JACCjournals @ACCinTouch @ACCmediacenter https://t.co/KvLWXnlM1H
-
-
Mashup Score: 1
The J Valve from JC Medical was linked to positive outcomes and “excellent” hemodynamic data after 30 days in an early feasibility study published in JACC: Cardiovascular Interventions. Researchers noted that the valve showed potential in patients with large aortic annuli, which represents an “unmet critical need” at this stage.
Source: cardiovascularbusiness.comCategories: General Medicine News, CardiologistsTweet-
New #TAVR valve for native aortic regurgitation linked to positive 30-day outcomes @hahn_rt @JoaoLCavalcante @azeemlatib @MReardon19 @ChristHospital @JACCjournals @ACCinTouch @ACCmediacenter https://t.co/KvLWXnlM1H
-
-
Mashup Score: 1Q&A: Interventional cardiologist breaks down SMART data and TAVR valve performance in patients with small annuli - 5 month(s) ago
Some of the most talked about data at ACC.24 were the results of a late-breaking clinical trial comparing different transcatheter aortic valve replacement (TAVR) valves in patients with a small aortic annulus.
Source: cardiovascularbusiness.comCategories: General Medicine News, CardiologistsTweet-
Q&A: Interventional cardiologist @SuzanneJBaron breaks down SMART data and #TAVR valve performance in patients with small annuli @Medtronic @MDT_StructHeart https://t.co/f0RPHfaUlj https://t.co/PQkkqJ6oNe
-
-
Mashup Score: 5Prediction model for leaflet thrombosis in patients undergoing transcatheter aortic valve implantation: the EFFORT study - 5 month(s) ago
Clinical Research in Cardiology – Leaflet thrombosis (LT) is a multifaceted and underexplored condition that can manifest following transcatheter aortic valve implantation (TAVI). The…
Source: link.springer.comCategories: General Medicine News, CardiologistsTweet-
Very interesting study. Predictive of valve thrombosis after #TAVR EFFORT score. Maybe 🤔 those blood tests and scoring systems is used routinely in the future. https://t.co/YDj7Rn61Z9
-
-
Mashup Score: 0
The self-expanding valve is not yet approved by the FDA, but care teams in other markets are reporting positive outcomes when patients go home the day after treatment.
Source: cardiovascularbusiness.comCategories: General Medicine News, CardiologistsTweet-
Boston Scientific #TAVR valve linked to positive outcomes after next-day discharge @bostonsci https://t.co/B0TouMfQMD
-
-
Mashup Score: 10
New research out of Cleveland Clinic explored long-term outcomes among patients with moderate aortic stenosis who were treated with TAVR, SAVR or clinical surveillance. TAVR and SAVR were both associated with clear improvements compared to surveillance alone.
Source: cardiovascularbusiness.comCategories: General Medicine News, Cardiology News and JournTweet-
AVR for moderate AS: New 10-year data highlight clear benefits of #TAVR, surgery @EssaHariri @habib_layoun @BadwanMD @Joseph_Kassab97 @tavrkapadia @CleClinicHVTI @ClevelandClinic @hopkinsheart @BritishCardioSo https://t.co/6D0UAmPXEQ
-
Not the trend that most expected… “In this cohort study, analysis of 210 495 patients in a large US registry cohort showed an increase in risk-adjusted odds for 30-day mortality [with #TAVR] after adjusting for patient and procedural characteristics.” https://t.co/ijdflHFbQW